Skip to main content
Clinical Trials/DRKS00024106
DRKS00024106
Completed
Phase 2

Evaluation of a cognitive-behavioral and systemic-solution-oriented short-term intervention to cope with fear of progression in families with children with cancer entitledShared fear, brave together

Selbstständige Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie0 sites31 target enrollmentMay 4, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
fear of progression
Sponsor
Selbstständige Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie
Enrollment
31
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 4, 2022
End Date
April 29, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Selbstständige Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

Eligibility Criteria

Inclusion Criteria

  • Children aged 0 to 17 years with a diagnosis of cancer and/or a parent or primary caregiver (e.g. legal guardian where applicable).
  • Patients in inpatient treatment at the pediatric oncology ward of the University Hospital Leipzig or in the aftercare phase at the association Elternhilfe für krebskranke Kinder Leipzig e.V.
  • Children and parents with sufficient German language skills (at least language level B1 according to GER).
  • Declaration of informed consent to study participation.

Exclusion Criteria

  • Patients in palliative care.
  • Patients with cognitive or physical impairments that would limit participation in the intervention.

Outcomes

Primary Outcomes

Not specified

Similar Trials